🚨 Exciting News! As we count down to #CellMech2025, we’re highlighting our incredible keynote speakers! 🌟
Prof. Georg Halder (@KU_Leuven & VIB) 🧬🔬 A pioneer in organ growth & cancer research, his lab uncovered the Hippo pathway and now studies liver regeneration & cancer🧠🧫
Prof. Georg Halder (@KU_Leuven & VIB) 🧬🔬 A pioneer in organ growth & cancer research, his lab uncovered the Hippo pathway and now studies liver regeneration & cancer🧠🧫
May 9, 2025 at 8:01 AM
🚨 Exciting News! As we count down to #CellMech2025, we’re highlighting our incredible keynote speakers! 🌟
Prof. Georg Halder (@KU_Leuven & VIB) 🧬🔬 A pioneer in organ growth & cancer research, his lab uncovered the Hippo pathway and now studies liver regeneration & cancer🧠🧫
Prof. Georg Halder (@KU_Leuven & VIB) 🧬🔬 A pioneer in organ growth & cancer research, his lab uncovered the Hippo pathway and now studies liver regeneration & cancer🧠🧫
UZ Leuven and VIB-KU Leuven Pioneering New Melanoma Treatment with First Patient Enrolled#Belgium#Leuven#UZ_Leuven#VIB-KU_Leuven#Presage_Biosciences
UZ Leuven and VIB-KU Leuven Pioneering New Melanoma Treatment with First Patient Enrolled
UZ Leuven and VIB-KU Leuven have begun a groundbreaking study focused on advanced melanoma treatments, marking the first patient enrolled in this promising trial.
third-news.com
April 3, 2025 at 5:35 AM
UZ Leuven and VIB-KU Leuven Pioneering New Melanoma Treatment with First Patient Enrolled#Belgium#Leuven#UZ_Leuven#VIB-KU_Leuven#Presage_Biosciences